297 related articles for article (PubMed ID: 7929473)
1. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release.
Takiyyuddin MA; Brown MR; Dinh TQ; Cervenka JH; Braun SD; Parmer RJ; Kennedy B; O'Connor DT
J Auton Pharmacol; 1994 Jun; 14(3):187-200. PubMed ID: 7929473
[TBL] [Abstract][Full Text] [Related]
2. Is physiologic sympathoadrenal catecholamine release exocytotic in humans?
Takiyyuddin MA; Cervenka JH; Sullivan PA; Pandian MR; Parmer RJ; Barbosa JA; O'Connor DT
Circulation; 1990 Jan; 81(1):185-95. PubMed ID: 2404624
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin 'A' in normal subjects, essential hypertensives and adrenalectomized patients.
Giampaolo B; Angelica M; Antonio S
Clin Endocrinol (Oxf); 2002 Jul; 57(1):41-50. PubMed ID: 12100068
[TBL] [Abstract][Full Text] [Related]
4. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
Mahapatra NR; Mahata M; Mahata SK; O'Connor DT
J Hypertens; 2006 May; 24(5):895-904. PubMed ID: 16612252
[TBL] [Abstract][Full Text] [Related]
5. Chromogranin A: localization and stoichiometry in large dense core catecholamine storage vesicles from sympathetic nerve.
O'Connor DT; Klein RL; Thureson-Klein AK; Barbosa JA
Brain Res; 1991 Dec; 567(2):188-96. PubMed ID: 1817725
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine sources of chromogranin-A in normal man: clues from selective stimulation of endocrine glands.
Takiyyuddin MA; Cervenka JH; Pandian MR; Stuenkel CA; Neumann HP; O'Connor DT
J Clin Endocrinol Metab; 1990 Aug; 71(2):360-9. PubMed ID: 2116438
[TBL] [Abstract][Full Text] [Related]
7. Subcellular storage and axonal transport of neuropeptide Y (NPY) in relation to catecholamines in the cat.
Fried G; Lundberg JM; Theodorsson-Norheim E
Acta Physiol Scand; 1985 Sep; 125(1):145-54. PubMed ID: 3840322
[TBL] [Abstract][Full Text] [Related]
8. Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies.
Takiyyuddin MA; Baron AD; Cervenka JH; Barbosa JA; Neumann HP; Parmer RJ; Sullivan PA; O'Connor DT
J Clin Endocrinol Metab; 1991 Mar; 72(3):616-22. PubMed ID: 1671783
[TBL] [Abstract][Full Text] [Related]
9. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin A, the major catecholamine storage vesicle soluble protein. Multiple size forms, subcellular storage, and regional distribution in chromaffin and nervous tissue elucidated by radioimmunoassay.
O'Connor DT; Frigon RP
J Biol Chem; 1984 Mar; 259(5):3237-47. PubMed ID: 6421820
[TBL] [Abstract][Full Text] [Related]
11. Effects of clonidine, dihydralazine and splanchnic nerve stimulation on the release of neuropeptide Y, MET-enkephalin and catecholamines from dog adrenal medulla.
Damase-Michel C; Tavernier G; Giraud P; Montastruc JL; Montastruc P; Tran MA
Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):379-84. PubMed ID: 7904052
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of sympathetic neuron neuropeptide Y and catecholamine content and secretion.
May V; Brandenburg CA; Braas KM
J Neurosci; 1995 Jun; 15(6):4580-91. PubMed ID: 7790925
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y-like immunoreactivity of plasma during hypoglycaemia in man.
Russell AE; Cain MD; Kapoor V; Morris MJ; Chalmers JP
J Auton Nerv Syst; 1989 Feb; 26(1):85-8. PubMed ID: 2708787
[TBL] [Abstract][Full Text] [Related]
14. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
Pernow J
Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma.
O'Connor DT; Bernstein KN
N Engl J Med; 1984 Sep; 311(12):764-70. PubMed ID: 6472366
[TBL] [Abstract][Full Text] [Related]
16. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.
Pernow J; Lundberg JM; Kaijser L; Hjemdahl P; Theodorsson-Norheim E; Martinsson A; Pernow B
Clin Physiol; 1986 Dec; 6(6):561-78. PubMed ID: 3466738
[TBL] [Abstract][Full Text] [Related]
17. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans.
Pernow J; Lundberg JM; Kaijser L
J Cardiovasc Pharmacol; 1988; 12(5):593-9. PubMed ID: 2468060
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A correlates with norepinephrine release rate.
Dimsdale JE; O'Connor DT; Ziegler M; Mills P
Life Sci; 1992; 51(7):519-25. PubMed ID: 1640800
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y inhibits the nicotine-mediated release of catecholamines from bovine adrenal chromaffin cells.
Higuchi H; Costa E; Yang HY
J Pharmacol Exp Ther; 1988 Feb; 244(2):468-74. PubMed ID: 3346832
[TBL] [Abstract][Full Text] [Related]
20. Spatial and activity-dependent catecholamine release in rat adrenal medulla under native neuronal stimulation.
Wolf K; Zarkua G; Chan SA; Sridhar A; Smith C
Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27597763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
